Recent progress of 1,3,4-oxadiazoles as anticonvulsants: Future horizons.

Nazar, Shagufi; Siddiqui, Nadeem; Alam, Ozair

Nazar, Shagufi; Siddiqui, Nadeem; Alam, Ozair.

Afiliação

Nazar S; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (Formerly Faculty of Pharmacy), Jamia Hamdard, Hamdard Nagar, New Delhi, India.
Siddiqui N; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (Formerly Faculty of Pharmacy), Jamia Hamdard, Hamdard Nagar, New Delhi, India.
Alam O; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research (Formerly Faculty of Pharmacy), Jamia Hamdard, Hamdard Nagar, New Delhi, India.

Arch Pharm (Weinheim) ; 353(7): e1900342, 2020 Jul.

Article em En | MEDLINE | ID: mdl-32319117

Assuntos

Anticonvulsivantes/uso terapêutico; Oxidiazóis/uso terapêutico; Convulsões/tratamento farmacológico; Anticonvulsivantes/síntese química; Anticonvulsivantes/química; Desenvolvimento de Medicamentos; Humanos; Oxidiazóis/síntese química; Oxidiazóis/química

Palavras-chave

1; 3; 4-oxadiazoles; MES; anticonvulsants; antiepileptic drugs; scPTZ test; seizure

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxidiazóis / Convulsões / Anticonvulsivantes Limite: Humans Idioma: En Revista: Arch Pharm (Weinheim) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google